X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Abbott India with Piramal Healthcare - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs PIRAMAL ENTERPRISES - Comparison Results

ABBOTT INDIA    Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

PIRAMAL ENTERPRISES 
   Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA PIRAMAL ENTERPRISES ABBOTT INDIA/
PIRAMAL ENTERPRISES
 
P/E (TTM) x 32.7 37.0 88.5% View Chart
P/BV x 8.2 3.7 221.7% View Chart
Dividend Yield % 0.8 0.7 124.6%  

Financials

 ABBOTT INDIA   PIRAMAL ENTERPRISES
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-16
PIRAMAL ENTERPRISES
Mar-16
ABBOTT INDIA/
PIRAMAL ENTERPRISES
5-Yr Chart
Click to enlarge
High Rs6,0151,065 564.8%   
Low Rs3,707805 460.5%   
Sales per share (Unadj.) Rs1,236.9383.0 322.9%  
Earnings per share (Unadj.) Rs122.255.1 221.8%  
Cash flow per share (Unadj.) Rs129.074.1 174.1%  
Dividends per share (Unadj.) Rs35.0017.50 200.0%  
Dividend yield (eoy) %0.71.9 38.5%  
Book value per share (Unadj.) Rs521.2719.9 72.4%  
Shares outstanding (eoy) m21.25172.56 12.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.92.4 161.0%   
Avg P/E ratio x39.817.0 234.4%  
P/CF ratio (eoy) x37.712.6 298.5%  
Price / Book Value ratio x9.31.3 718.0%  
Dividend payout %28.631.8 90.2%   
Avg Mkt Cap Rs m103,296161,344 64.0%   
No. of employees `0003.03.8 78.1%   
Total wages/salary Rs m3,37016,898 19.9%   
Avg. sales/employee Rs Th8,891.817,472.6 50.9%   
Avg. wages/employee Rs Th1,140.04,466.9 25.5%   
Avg. net profit/employee Rs Th878.32,512.8 35.0%   
INCOME DATA
Net Sales Rs m26,28466,099 39.8%  
Other income Rs m5042,425 20.8%   
Total revenues Rs m26,78968,524 39.1%   
Gross profit Rs m3,66518,723 19.6%  
Depreciation Rs m1443,274 4.4%   
Interest Rs m89,388 0.1%   
Profit before tax Rs m4,0178,485 47.3%   
Minority Interest Rs m03 0.0%   
Prior Period Items Rs m01,593 0.0%   
Extraordinary Inc (Exp) Rs m0457 0.0%   
Tax Rs m1,4211,032 137.7%   
Profit after tax Rs m2,5969,506 27.3%  
Gross profit margin %13.928.3 49.2%  
Effective tax rate %35.412.2 290.9%   
Net profit margin %9.914.4 68.7%  
BALANCE SHEET DATA
Current assets Rs m14,44647,488 30.4%   
Current liabilities Rs m4,725104,362 4.5%   
Net working cap to sales %37.0-86.0 -43.0%  
Current ratio x3.10.5 671.9%  
Inventory Days Days5141 126.6%  
Debtors Days Days2051 38.2%  
Net fixed assets Rs m1,11326,532 4.2%   
Share capital Rs m213345 61.6%   
"Free" reserves Rs m10,808114,024 9.5%   
Net worth Rs m11,076124,221 8.9%   
Long term debt Rs m075,812 0.0%   
Total assets Rs m16,241308,356 5.3%  
Interest coverage x497.01.9 26,103.0%   
Debt to equity ratio x00.6 0.0%  
Sales to assets ratio x1.60.2 755.0%   
Return on assets %16.06.1 261.7%  
Return on equity %23.47.7 306.3%  
Return on capital %36.310.0 364.8%  
Exports to sales %0.617.2 3.6%   
Imports to sales %12.66.6 191.5%   
Exports (fob) Rs m16211,362 1.4%   
Imports (cif) Rs m3,3224,364 76.1%   
Fx inflow Rs m26814,435 1.9%   
Fx outflow Rs m3,9275,183 75.8%   
Net fx Rs m-3,6599,253 -39.5%   
CASH FLOW
From Operations Rs m2,514-67,773 -3.7%  
From Investments Rs m-800-8,768 9.1%  
From Financial Activity Rs m-80376,199 -1.1%  
Net Cashflow Rs m912-342 -266.3%  

Share Holding

Indian Promoters % 0.0 52.9 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.9 4.0 197.5%  
FIIs % 0.1 26.6 0.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 16.5 103.6%  
Shareholders   18,270 93,274 19.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   AUROBINDO PHARMA  MERCK LTD  GSK PHARMA  VENUS REMEDIES  IPCA LABS  

Compare ABBOTT INDIA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens in Green; Tata Stocks in Focus(09:30 am)

Asian stock indices are lower today as Japanese and Hong Kong shares fall. The Nikkei 225 is off 0.13% while the Hang Seng is down 0.54%. The Shanghai Composite is trading down by 0.02%.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

Dear PM Modi, India is Already Land of Self-Employed, and It Ain't Working(Vivek Kaul's Diary)

Aug 21, 2017

Most Indians who cannot find jobs, look at becoming self-employed.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

Think Twice Before You Keep Money In A Savings Bank Account(Outside View)

Aug 22, 2017

Post demonetisation, a cut in bank savings deposits rates was in the offing.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Aug 24, 2017 11:01 AM

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 5-YR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS